- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Volumetric and MGMT parameters in glioblastoma patients: Survival analysis ; volume:12 ; number:1 ; day:3 ; month:1 ; year:2012 ; pages:1-13 ; date:12.2012
BMC cancer ; 12, Heft 1 (3.1.2012), 1-13, 12.2012
- Creator
-
Iliadis, Georgios
- Contributor
-
Kotoula, Vassiliki
Chatzisotiriou, Athanasios
Televantou, Despina
Eleftheraki, Anastasia G.
Lambaki, Sofia
Misailidou, Despina
Selviaridis, Panagiotis
Fountzilas, George
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-12-3
- URN
-
urn:nbn:de:1111-20160304570
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Iliadis, Georgios
- Kotoula, Vassiliki
- Chatzisotiriou, Athanasios
- Televantou, Despina
- Eleftheraki, Anastasia G.
- Lambaki, Sofia
- Misailidou, Despina
- Selviaridis, Panagiotis
- Fountzilas, George
- SpringerLink (Online service)
Other Objects (12)
PLEKHG5 regulates autophagy, survival and MGMT expression in U251-MG glioblastoma cells
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
Mitochondria‐Targeted Temozolomide Probe for Overcoming MGMT‐Mediated Resistance in Glioblastoma
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Deep learning for glioblastoma segmentation using preoperative magnetic resonance imaging identifies volumetric features associated with survival
PLEKHG5 regulates autophagy, survival and MGMT expression in U251-MG glioblastoma cells
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
Mitochondria‐Targeted Temozolomide Probe for Overcoming MGMT‐Mediated Resistance in Glioblastoma
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Deep learning for glioblastoma segmentation using preoperative magnetic resonance imaging identifies volumetric features associated with survival
PLEKHG5 regulates autophagy, survival and MGMT expression in U251-MG glioblastoma cells
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
Mitochondria‐Targeted Temozolomide Probe for Overcoming MGMT‐Mediated Resistance in Glioblastoma
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy